Synthesis, luminescent properties and antibacterial activity of new pyrazoline and pyrimidine derivatives of (2e)-1-biphenyl-3-arylprop-2-en-1-ones

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Substituted prop-2-en-1-ones were obtained by the condensation reaction of 1-biphenyl-4-yl-ethanone with aromatic aldehydes in the presence of sodium hydroxide in an aqueous ethanol solution. Subsequent cyclization of the latter with hydrazine hydrate, phenylhydrazine, and thiosemicarbazide in an acidic medium leads to the corresponding pyrazolines. The reaction of amidine hydrochlorides with chalcones in a KOH-ethanol system leads to 2,4,6-trisubstituted pyrimidines. The luminescent and antibacterial properties of the resulting systems was studied.

作者简介

A. Isakhanyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

Email: anush.isakhanyan.51@mail.ru

N. Hakobyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

Z. Hovasyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

G. Grigoryan

Yerevan State University

R. Mkhitaryan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

H. Aracelyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

A. Safaryan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

R. Muradyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

H. Panosyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

参考

  1. Li J.-T., Zhang X.-H., Lin Z.-P. // Beilstein J. Org. Chem. 2007. Vol. 3. N 13. doi: 10.1186/1860-5397-3-13
  2. Li Q.S., Shen B.N., Zhang Z., Luo S., Ruan B.F. // Curr. Med. Chem. 2021. Vol. 28. N 5. P. 940. doi: 10.2174/0929867327666200306120151
  3. Patil S.B. // Int. J. Pharm. Sci. Res. 2018. Vol. 9. N 1. P. 44. doi: 10.13040/IJPSR.0975-8232.9(1).44-52
  4. Elkanzi N.A.A. // Orient. J. Chem. 2020. Vol. 36. N 6. P. 1001. doi: 10.13005/ojc/360602
  5. Sviripa V.M., Zhang W., Balia A.G., Tsodikov O.V., Nickell J.R., Gizard F., Yu T., Lee E.Y., Dwoskin L.P., Watt D.S. // J. Med. Chem. 2014. Vol. 57. P. 6083. doi: 10.1021/jm5004864
  6. Varghese B., Al-Busafi S.N., Suliman F.O., AlKindy S.M.Z. // RSC Adv. 2017. Vol. 7. P. 46999. doi: 10.1039/C7RA08939B
  7. Selivanova D.G., Gorbunov A.A., Mayorova O.A., Vasyanin A.N., Lunegov I.V., Shklyaeva E.V., Abashev G.G. // Beilstein J. Org. Chem. 2017. Vol. 13. P. 1583. doi: 10.3762/bjoc.13.158.
  8. Achelle S., Rodríguez-Lopez J., Larbani M., Plaza-Pedroche R., Robin-le Guen F. // Molecules. 2019. Vol. 24. P. 1742. doi: 10.3390/molecules24091742
  9. Shivananda M.K., Holla B.S. // J. Chem. Pharm. Res. 2017. Vol. 9. N 6. P. 1.
  10. Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. М.: Медицина, 2012. С. 509.
  11. Машковский М.Д. Лекарственные средства. М.: Новая волна, 2010. С. 851.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russian Academy of Sciences, 2023